抗体效价(log2)
/ q# [) n/ _3 j# ] | 攻毒数
) ^) Q& w" Y9 {. w' Q0 i: f. m | 死亡数
/ W- r& Z3 n! Q3 B) P | 存活数
5 a- ~& @: g' V# A2 j | 保护率%
1 ]' h3 p5 }3 }8 z |
03 r8 {0 o! t% ^: r' s5 W3 P! o
| 6' ^7 N. ]3 E, b4 f" i5 x
| 6" ^1 q) G( `( v7 i
| 0, A6 x" z' H" G! P/ q
| 06 h. h7 f" P% a; {* F& A
|
1
f7 N( ^! G0 s$ S% O | 6
3 {4 \& o- K+ \; H | 6
9 I/ P1 M1 P/ w1 t& H | 0
6 C, t& c; ~# w# c" L" e3 F | 0
" S* G# j/ U9 A. M |
2 / m( ~5 ^ \: I" I T1 L* k$ I
| 6 0 |- ]8 Z3 e3 [ ]5 [2 _
| 3 * Y2 J0 ^+ k/ X" t8 O! [7 c4 `3 F# g
| 3
8 Z- M5 u' ~& q; z: B | 50 / |# X& f, c& ^# ]4 ~7 `
|
3
% v) x" h5 a# @# z+ u | 6 : t. v: K. s* |% e% N. j$ b" ]
| 0 ! W& c: R _6 E" X! Z
| 6
) w' j) R5 [& I# B | 100 , S! R ~+ x. w0 i
|
4 8 E o+ C1 b6 }$ g& P9 e# J: w9 g
| 6 % @: B0 B- \6 x" x; g5 N/ D
| 0
$ q9 y! n& ]' {0 T | 6 ! o8 @8 w% D G+ C! b; R0 m9 [) M
| 100 2 H' s& N! M9 i/ [" `! A8 f1 J5 Z7 C
|
8 F4 X& B+ `$ F6 O日龄, S" @" l+ J* f5 w+ ?+ z- P! f
|
& G9 x4 m) D( }4 t8 `, \% d免疫后
$ v& U4 |5 s) @ |
1周 7 k/ b& ]6 C: M5 Q f
| 2周
1 t8 w9 }$ Q" X1 f- x | 3周
: X1 Q' r* Z0 Y/ R' D7 Q | 4周 2 E# m: w. G% O
| 5周 8 l) l; @3 S/ C
| 6周
+ c, h- H9 a. T9 B; ]- |* R | 7周
! C) m- Q$ s, s" I% g | 8周 0 @+ M5 s/ k+ I7 [/ N" d- [5 j
|
30
6 i$ ?" `3 v3 V | 1.67±0.58c* `+ b, ?( f( M+ X0 I9 n% R
| 2.75±0.96bc, K! S) R: `7 v0 K6 ~0 s+ M
| 1.75±0.96b
; o- C7 S: F+ T7 a% ^ | 1.00±0.00d
' t: r- E) v. S | 0.25±0.50c9 K: X- W# b( F" V! j- W( o1 R
| 0.13±0.25c
' L y' @& l+ f | 0
* c) d6 B; w$ P V% t" H | 0" c; X# Q$ Z, y9 c4 {7 T
|
35
3 W( W0 U+ F- @% ?- q | 3.25±0.50ab# `, P" `: U+ I2 f5 V
| 3.00±0.82bc6 r# g+ f4 G: Y2 m, t% z! k8 N
| 2.38±0.49b
8 H3 s" G! G* D | 2.00±0.00c2 i* u- D6 U6 x7 F; A
| 1.00±0.00c
" @; a. V3 _3 O5 O | 0.75±0.50c; ~( A8 b# N1 p/ {1 M( t% k, p" l
| 0' D4 i- H6 ^& c0 T9 s. X5 Q. k; C
| 0
, A/ b+ ~: q3 l* @: D# d |
40/ ^0 y& ~# ?" `8 P0 v
| 3.00±0.82ab. C5 }" S3 c: k* q
| 5.75±1.71a
' B' ]% n9 v0 I- j# y7 p* o | 5.00±1.83a
* {3 m5 N! t% Q S& T) j7 v( l | 3.25±1.50b+ t/ Q( Z8 `2 ?) D0 i
| 3.00±0.82b
: B* R8 f5 i4 o1 R9 ?7 u | 2.13±0.50b
|; m3 z% C1 h0 e8 Q | 1.83±0.58bc8 T! [& W0 b& r. ^. l, @
| 1.03±0.63bc
: ?# }) ^6 S2 k9 l0 }' O0 t$ U |
45
3 L$ z8 A) S3 \ | 3.25±1.26ab; b; Z, W4 \& ?; i% A% G
| 4.25±0.96ab. }) v0 B# h8 t3 T9 D
| 5.50±1.29a2 c! f7 S/ i+ z$ _
| 3.75±0.96b
! J' k; L! c+ p8 `- B | 3.25±1.26b F; Y$ y& {) l- k/ f- L- X% k
| 2.38±1.80b3 U% R; K: X, e4 M6 o
| 2.00±1.41bc
& X6 r# L' p9 i) |/ R t | 1.13±0.63bc& t& n9 P' [. g2 w2 I9 C I
|
50- S3 r( [3 h$ Q$ r
| 2.25±0.50bc
+ z3 p9 ^+ H% C ?1 {$ K1 T) k | 4.25±0.96ab
9 i/ h( N0 w* }' l | 4.50±2.08a& ]% e% R& c4 V+ D
| 5.75±0.50a8 `3 ~: e+ @9 x1 }9 j7 {" m$ B2 g
| 6.00±0.00a8 q! M& Z) r: V
| 5.00±0.00a
, j9 z( V6 ~0 i2 `, U | 3.5±0.58ab
! Y5 D( m; Z+ v6 V: c! ]4 L | 1.50±0.58b
, A; \: S: v9 d$ b7 @7 [ X |
550 ]7 @% t6 y, D, x
| 3.50±0.58a1 P4 u1 Z4 b- v$ s3 R
| 4.75±0.50a
7 @0 Y6 d& j" v) c2 L) Y | 6.00±0.82b
$ f) u8 T0 S4 I P( j7 z | 5.75±1.50a
Q9 I# l; t+ _: O# ?; x* a | 5.25±0.96a3 k( P; `4 ?5 {
| 4.25±0.50a* ]# U+ m2 ^3 j* x7 |3 D; x/ c
| 3.25±0.96b
3 [- C3 c( W$ c0 A. v, u! d | 2.75±1.26ab
4 W! i m/ d# a7 N( S |
60) f) _0 f; G% c: z: c
| 3.50±0.58a7 d8 [: J* c7 g' E- t+ t7 P
| 5.00±0.82a
* B/ L' r, o/ B& c0 X9 w0 x | 6.25±0.50a: h# Q% W2 i) D, S) h9 n. {4 Z
| 5.75±0.96a- W" @8 P2 S" V7 e# G r
| 5.00±0.82a
5 } d& Q" q6 ]& g3 R | 4.13±0.85a( w. N" T, i* i' C$ f; e1 X
| 3.25±0.96b
- @% t; c& G% L: c, `& O) o+ ?& y | 2.25±0.96b
' Z8 L3 m2 j+ W8 \2 C8 T$ n+ D |